Global Cord Blood Corporation
CORBF
$1.02
-$0.13-11.30%
| 03/31/2022 | 09/30/2021 | 03/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 171.50M | 167.80M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 171.50M | 167.80M | |
| Cost of Revenue | -- | -- | 26.46M | 25.60M | |
| Gross Profit | -- | -- | 145.05M | 142.20M | |
| SG&A Expenses | -- | -- | 60.96M | 59.93M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 90.95M | 88.73M | |
| Operating Income | -- | -- | 80.56M | 79.07M | |
| Income Before Tax | -- | -- | 90.15M | 85.39M | |
| Income Tax Expenses | -- | -- | 13.95M | 15.04M | |
| Earnings from Continuing Operations | -- | -- | 76.20 | 70.35 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -1.18M | -1.15M | |
| Net Income | -- | -- | 75.02M | 69.20M | |
| EBIT | -- | -- | 80.56M | 79.07M | |
| EBITDA | -- | -- | 87.67M | 86.06M | |
| EPS Basic | -- | -- | 0.62 | 0.57 | |
| Normalized Basic EPS | -- | -- | 0.23 | 0.22 | |
| EPS Diluted | -- | -- | 0.62 | 0.57 | |
| Normalized Diluted EPS | -- | -- | 0.23 | 0.22 | |
| Average Basic Shares Outstanding | -- | -- | 486.20M | 485.80M | |
| Average Diluted Shares Outstanding | -- | -- | 486.20M | 485.80M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
